Technology
Health
Therapy

Krystal Biotech

913

$37.76
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$3.18 (-7.77%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell KRYS and other stocks, options, ETFs, and crypto commission-free!

About KRYS

Krystal Biotech, Inc. Common Stock, also called Krystal Biotech, is a gene therapy company, which engages in developing and commercializing treatment for patients suffering from dermatological diseases. Read More It developed a gene therapy platform, which company refer to as the Skin TARgeted Delivery platform, or STAR-D platform, that consists of a patent pending engineered viral vector based on herpes simplex virus 1, or HSV-1, and skin-optimized gene transfer technology, to develop off-the-shelf treatments for dermatological diseases for which company believe there are no known effective treatments. The company was founded by Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.

CEO
Krish S. Krishnan
Employees
51
Headquarters
Pittsburgh, Pennsylvania
Founded
2016
Market Cap
742.39M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
216.37K
High Today
$41.55
Low Today
$37.69
Open Price
$41.24
Volume
169.01K
52 Week High
$66.85
52 Week Low
$31.89

Collections

Technology
Health
Therapy
2017 IPO
US
North America

KRYS Earnings

-$0.37
-$0.25
-$0.12
$0.00
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Expected Aug 3, After Hours

You May Also Like

IPWR
QMJ
ACAD
SVT
HYT
PPMC
NKG
DIT
YTRA
RBC
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy KRYS

Market Price$37.76
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell KRYS stock and options commission-free.
LearnBlogCareersHelpLog InSign Up